Electroporation is a technology that increases cell membrane permeability by the application of electric pulses. Electrochemotherapy (ECT), the best-known application of electroporation, is a very effective local treatment for tumors of any histology in human and veterinary medicine. It induces a local yet robust immune response that is responsible for its high effectiveness. Gene electrotransfer (GET), used in research to produce a systemic immune response against cancer, is another electroporation-based treatment that is very appealing for its effectiveness, low cost, and simplicity. In this review, we present the immune effect of electroporation-based treatments and analyze the results of the vast majority of the published papers related to immune response enhancement by gene electrotransfer in companion animals with spontaneous tumors. In addition, we present a brief history of the initial steps and the state of the art of the electroporation-based treatments in Latin America. They have the potential to become an essential form of immunotherapy in the region. This review gives insight into the subject and helps to choose promising research lines for future work; it also helps to select the adequate treatment parameters for performing a successful application of this technology.
CITATION STYLE
Maglietti, F., Tellado, M., De Robertis, M., Michinski, S., Fernández, J., Signori, E., & Marshall, G. (2020, September 1). Electroporation as the immunotherapy strategy for cancer in veterinary medicine: State of the art in Latin America. Vaccines. MDPI AG. https://doi.org/10.3390/vaccines8030537
Mendeley helps you to discover research relevant for your work.